Pediatric heart failure therapy: why β1-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker?

Pediatric heart failure (HF) treatment lagged behind the knowledge of pharmacological research and evidence-based clinical experience in adults. Considering the lack of prospective, double blind randomized studies in children, the review is focused on the preferred indication of specific β1-adrenore...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Pediatr
Asıl Yazarlar: Recla, Sabine, Schmidt, Dorle, Logeswaran, Thushiha, Esmaeili, Anoosh, Schranz, Dietmar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2019
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514284/
https://ncbi.nlm.nih.gov/pubmed/31161079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp.2019.04.08
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller